- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02420249
Qigong for Breast Cancer Survivors
Randomised Controlled Trial of Qigong Training Programme to Alleviate Arm Oedema, ¬Reduce Shoulder Impairment, Improve Body Balance and Quality of Life in Community-dwelling Breast Cancer Survivors
Objectives: (1) To investigate the effects of Qigong training on upper limb oedema, circulatory status, shoulder flexibility and muscular strength, body balance, and quality of life (QOL) in community-dwelling breast cancer survivors; and (2) to explore the relationship between the impairment outcomes and QOL outcomes.
Hypothesis: (1) The experimental participants will have less impairment and a better QOL after Qigong training compared with the no-training control group; and (2) the impairment parameters will be related to the QOL indexes in the Qigong participants.
Design and subjects: This will be a prospective, randomised, single-blinded controlled trial. Approximately 60 breast cancer survivors will be randomly assigned to either the Qigong training group (n~30) or control group (n~30).
Intervention: Participants in the Qigong group will receive 18 Forms of Tai Chi Internal Qigong training for 3 months with two supervised 1-hour sessions per week.
Main outcome measures: The primary outcome measures are upper limb circumference, arterial blood flow velocities and resistance index, shoulder joint passive range of motion, muscular strength (peak force) and body balance. The secondary outcome measure is quality of life as measured by the Functional Assessment of Cancer Therapy - Breast scale.
Data analysis: Data will be analysed via repeated-measures analysis of variance followed by post-hoc tests (α = 0.05).
Expected results: The investigators pilot studies produced encouraging results on the efficacy of Qigong exercise in reducing chronic breast cancer-related symptoms in survivors. Therefore, the investigators expect that participants in the Qigong group will have fewer upper limb impairments and a better quality of life after Qigong training. If the results are positive, this Qigong training regime is readily transferrable to clinical practice, and could have positive socioeconomic effects such as reduced healthcare costs.
Studieoversikt
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Pokfulam, Hong Kong
- Rekruttering
- University of Hong Kong
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
The inclusion criteria are
- history of a breast malignancy of any stage
- history of mastectomy or lumpectomy with or without adjuvant chemotherapy or radiotherapy
- having completed conventional cancer treatment and medically stable
- no known neurological deficits resulting from breast cancer treatment or other neurological disorders
- persistent lymphoedema defined as a circumference difference greater than 2 cm at any point between the surgical upper limb and contralateral upper limb13
- female aged 18 or above.
Exclusion Criteria:
The exclusion criteria are
- presence of major psychiatric, neurological, musculoskeletal, cardiovascular, peripheral vascular or kidney disorder
- receiving conventional cancer treatments such as chemotherapy or radiotherapy, medications such as diuretics or traditional Chinese medicine
- recurrent cancer or cancer that has spread to another organ
- participation in regular physical activity
- prior experience of Qigong or Tai Chi
- a smoking habit
- pregnancy during the study period.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Qigong training group
Participants assigned to the Qigong group will receive Qigong training.
The Qigong training programme will be run for 3 months with two supervised 1-hour sessions per week.
Participants will learn the 18 Forms of Tai Chi Internal Qigong.
The training sessions will be conducted by a qualified Qigong instructor from the Natural Health Qigong Association.
Participants in the control group will receive no Qigong training during the study period.
They will receive an 18 Forms of Tai Chi Internal Qigong training package after the study.
|
Participants will learn the 18 Forms of Tai Chi Internal Qigong.
Detailed movement and breathing descriptions of the Qigong training protocol can been found in Mak YK. 18 Forms Tai Chi Qigong [in Chinese].
7th ed.
Hong Kong: Wan Li Book Co.; 2012.
|
|
Ingen inngripen: Control group
Participants in the control group will receive no Qigong training.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in upper limb circumference
Tidsramme: Baseline (0 month) and post-intervention (3 months)
|
Circumference of both arms will be measured using a cloth measuring tape.
|
Baseline (0 month) and post-intervention (3 months)
|
|
Change in arterial resistance and blood flow velocities
Tidsramme: Baseline (0 month) and post-intervention (3 months)
|
A Doppler ultrasound machine will be used to examine the arterial blood flow velocities.
|
Baseline (0 month) and post-intervention (3 months)
|
|
Change in shoulder flexibility
Tidsramme: Baseline (0 month) and post-intervention (3 months)
|
A universal goniometer will be used to measure the passive range of motion (ROM) of bilateral shoulder abduction and horizontal abduction.
|
Baseline (0 month) and post-intervention (3 months)
|
|
Change in shoulder muscular strength
Tidsramme: Baseline (0 month) and post-intervention (3 months)
|
The maximum isometric muscular strength of the shoulder flexor, abductor, internal rotator and external rotator muscles will be measured bilaterally using the Lafayette Manual Muscle Test System.
|
Baseline (0 month) and post-intervention (3 months)
|
|
Change in body balance
Tidsramme: Baseline (0 month) and post-intervention (3 months)
|
Standing balance of the participants will be measured using timed single leg standing test.
|
Baseline (0 month) and post-intervention (3 months)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in quality of life
Tidsramme: Baseline (0 month) and post-intervention (3 months)
|
Functional Assessment of Cancer Therapy - Breast scale version 4 will be used.
|
Baseline (0 month) and post-intervention (3 months)
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 201410159001
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Neoplasmer
-
Guangzhou First People's HospitalFullført
-
Technische Universität DresdenHar ikke rekruttert ennåMDS (myelodysplastisk syndrom) | CCUS klonal cytopeni av ubestemt betydning | MDS/Myeloproliferative Neoplasm (MPN) overlappingssyndrom | CHIPTyskland
-
Rabin Medical CenterFullførtDesmoid fibromatose | Desmoid | Desmoid fibromatose i huden | Desmoid Neoplasm of Chest Wall | Desmoid-svulst forårsaket av somatisk mutasjon | Aggressive fibromatoser | Fibromatose DesmoidIsrael
-
Chongqing Precision Biotech Co., LtdRekrutteringAML (akutt myeloid leukemi) | BPDCN (blastisk Plasmacytoid Dendritic Cell Neoplasm)Kina
-
Beijing BiotechRekrutteringPerifert T-celle lymfom | T-lymfoblastisk lymfom | Relapset/Refraktær B-celle akutt lymfatisk leukemi | Resistent/refraktær B-celle non-Hodgkin lymfom eller CLL/SLL | Relapserende/Refraktær Multipl Myelom eller Plasmacelleleukemi | Relapset/Refraktær Akutt Myeloid Leukemi, Høyrisiko Myelodysplastisk... og andre forholdKina
-
Prelude TherapeuticsBeiGeneFullførtMarginal sone lymfom | Akutt myeloid leukemi (AML) | Kronisk myelomonocytisk leukemi (CMML) | Myelodysplastisk syndrom (MDS) | T-celle lymfom | Mantelcellelymfom (MCL) | Diffust storcellet B-celle lymfom (DLBCL) | Richters syndrom | Myeloide maligniteter | Aggressiv B-celle non-Hodgkins lymfom (NHL) | Kronisk... og andre forholdForente stater, Canada, Australia, Frankrike, Italia, Storbritannia, Sør -Korea, Tyskland, Polen, Sveits
Kliniske studier på Qigong training
-
Florida International UniversityArizona State UniversityFullførtMental Helse | Fysisk helseForente stater
-
Tri-Service General HospitalFullførtKognitiv dysfunksjon | Trening | Kognitiv nedgang | Kognitiv aldring | Grep | Fysisk utholdenhet
-
Ching-I ChangTaipei Hospital, TaiwanFullførtLivskvalitet | Brystkreft | Intraoperativ bevissthetTaiwan
-
Nova Scotia Health AuthorityFullførtKronisk smerte
-
Akdeniz UniversityFullførtLivskvalitet | Postoperativ smerte | Muskel svakhet | Smerter, skulder | Tap av respirasjonsfunksjon | LeddvedheftTyrkia
-
Eman Mohamed othmanHar ikke rekruttert ennå
-
Kaohsiung Medical University Chung-Ho Memorial...Kaohsiung Medical UniversityUkjent
-
University of HoustonBrigham and Women's Hospital; Texas Woman's UniversityAktiv, ikke rekrutterendeLivskvalitet | Fysisk funksjon | Pleier NødForente stater
-
Charite University, Berlin, GermanyFullført
-
The University of Hong KongFullført